Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clovis Oncology, Inc. - Common Stock (NQ: CLVS )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clovis Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc... 
Via Benzinga
Clovis Oncology to Announce Fourth Quarter 2021 and Year End 2021 Financial Results and Host Webcast Conference Call
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology Highlights FAP-2286 Preclinical Data Presented at the Targeted Radiopharmaceuticals Summit
From Clovis Oncology, Inc.
Via Business Wire
63 Biggest Movers From Friday
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
Ocugen Needs More Than Covaxin to Boost Its Falling Shares
A doomed-looking vaccine partnership puts Ocugen back in the business of obscurity and OCGN stock at risk of much lower prices. 
Via InvestorPlace
Global Metastatic Cancer Treatment Market Size Is Forecasted To Reach $111.16 Million By 2027
Palm Beach, FL – November 3, 2021 – FinancialNewsMedia.com News Commentary – The metastatic cancer treatment systems market is observing high demand attributed to its increasing application in breast,... 
Via FinancialNewsMedia
Clovis Oncology Announces Third Quarter 2021 Operating Results
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology to Announce Third Quarter 2021 Financial Results and Host Webcast Conference Call on November 3
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement
From Clovis Oncology, Inc.
Via Business Wire
Pan-Cancer Analysis Suggests Fibroblast Activation Protein (FAP) is an Attractive Target for Peptide-Targeted Radionuclide Therapy with FAP-2286
From Clovis Oncology, Inc.
Via Business Wire
Global Radiotherapy Market Expected To Reach $7.3 Billion with a CAGR Of 4.2% By 2026
Via FinancialNewsMedia
Clovis Oncology Retires Remaining 2021 Notes and Raises Additional Capital through its ATM Equity Offering Program
From Clovis Oncology, Inc.
Via Business Wire
Why Clovis Oncology Shares Got a Bump This Week
Shares of the biotech that focuses on oncology drugs climbed more than 12% during the week. 
Via The Motley Fool
Clovis Oncology Announces Renewal of At-The-Market Equity Offering Program
From Clovis Oncology, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6... 
Via Benzinga
Clovis Oncology Announces Second Quarter 2021 Operating Results
From Clovis Oncology, Inc.
Via Business Wire
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Exposures COVID-19
Clovis Oncology to Announce Second Quarter 2021 Financial Results and Host Webcast Conference Call on August 4
From Clovis Oncology, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on Tuesday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares... 
Via Benzinga
Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors
From Clovis Oncology, Inc.
Via Business Wire
What's Going On With Clovis Oncology Stock?
Clovis Oncology Inc. (NASDAQ: CLVS) shares gapped up Monday morning but have since fallen back to trading down on the day. There looks to be no company news acting as a catalyst... 
Via Benzinga
Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
Via FinancialNewsMedia
Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for Enrollment
From Clovis Oncology, Inc.
Via Business Wire
2 Great Reasons to Buy This Cancer Treatment Stock Now
When future promise meets hype, it's hard to deny the potential. 
Via The Motley Fool
Here's Why Wall Street Is Betting Against Clovis Oncology
The biotech is getting the sort of attention that its short-sellers would rather avoid. 
Via The Motley Fool
Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders
From Clovis Oncology, Inc.
Via Business Wire
62 Biggest Movers From Yesterday
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.